1. Home
  2. BEAM vs LMND Comparison

BEAM vs LMND Comparison

Compare BEAM & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • LMND
  • Stock Information
  • Founded
  • BEAM 2017
  • LMND 2015
  • Country
  • BEAM United States
  • LMND United States
  • Employees
  • BEAM N/A
  • LMND N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • LMND Property-Casualty Insurers
  • Sector
  • BEAM Health Care
  • LMND Finance
  • Exchange
  • BEAM Nasdaq
  • LMND Nasdaq
  • Market Cap
  • BEAM 1.9B
  • LMND 2.0B
  • IPO Year
  • BEAM 2020
  • LMND 2020
  • Fundamental
  • Price
  • BEAM $23.58
  • LMND $50.33
  • Analyst Decision
  • BEAM Buy
  • LMND Hold
  • Analyst Count
  • BEAM 11
  • LMND 6
  • Target Price
  • BEAM $45.90
  • LMND $32.20
  • AVG Volume (30 Days)
  • BEAM 1.3M
  • LMND 3.6M
  • Earning Date
  • BEAM 11-05-2024
  • LMND 10-30-2024
  • Dividend Yield
  • BEAM N/A
  • LMND N/A
  • EPS Growth
  • BEAM N/A
  • LMND N/A
  • EPS
  • BEAM N/A
  • LMND N/A
  • Revenue
  • BEAM $349,643,000.00
  • LMND $492,500,000.00
  • Revenue This Year
  • BEAM N/A
  • LMND N/A
  • Revenue Next Year
  • BEAM $6.04
  • LMND $26.74
  • P/E Ratio
  • BEAM N/A
  • LMND N/A
  • Revenue Growth
  • BEAM 328.73
  • LMND 22.09
  • 52 Week Low
  • BEAM $20.84
  • LMND $14.03
  • 52 Week High
  • BEAM $49.50
  • LMND $52.18
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 45.28
  • LMND 88.38
  • Support Level
  • BEAM $23.67
  • LMND $31.41
  • Resistance Level
  • BEAM $25.87
  • LMND $35.17
  • Average True Range (ATR)
  • BEAM 2.23
  • LMND 3.36
  • MACD
  • BEAM -0.24
  • LMND 2.00
  • Stochastic Oscillator
  • BEAM 19.58
  • LMND 93.55

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

Share on Social Networks: